<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>23(23)</volume><submitter>Casas-Aparicio G</submitter><pubmed_abstract>In hospitalized COVID-19 patients, disease progression leading to acute kidney injury (AKI) may be driven by immune dysregulation. We explored the role of urinary cytokines and their relationship with kidney stress biomarkers in COVID-19 patients before and after the development of AKI. Of 51 patients, 54.9% developed AKI. The principal component analysis indicated that in subclinical AKI, epidermal growth factor (EGF) and interferon (IFN)-α were associated with a lower risk of AKI, while interleukin-12 (IL-12) and macrophage inflammatory protein (MIP)-1β were associated with a higher risk of AKI. After the manifestation of AKI, EGF and IFN-α remained associated with a lower risk of AKI, while IL-1 receptor (IL-1R), granulocyte-colony stimulating factor (G-CSF), interferon-gamma-inducible </pubmed_abstract><journal>International journal of molecular sciences</journal><pagination>15419</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9737068</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Longitudinal Analysis of Urinary Cytokines and Biomarkers in COVID-19 Patients with Subclinical Acute Kidney Injury.</pubmed_title><pmcid>PMC9737068</pmcid><pubmed_authors>Calderon-Davila N</pubmed_authors><pubmed_authors>Olmedo-Ocampo R</pubmed_authors><pubmed_authors>Luna-Villalobos Y</pubmed_authors><pubmed_authors>Piekarska K</pubmed_authors><pubmed_authors>Avila-Rios S</pubmed_authors><pubmed_authors>Juarez-Diaz A</pubmed_authors><pubmed_authors>Leon-Rodriguez I</pubmed_authors><pubmed_authors>Figueroa-Hernandez L</pubmed_authors><pubmed_authors>Escamilla-Illescas D</pubmed_authors><pubmed_authors>Gonzalez-Navarro M</pubmed_authors><pubmed_authors>Piten-Isidro E</pubmed_authors><pubmed_authors>Peralta-Prado AB</pubmed_authors><pubmed_authors>Alvarado-de la Barrera C</pubmed_authors><pubmed_authors>Casas-Aparicio G</pubmed_authors><pubmed_authors>Castillejos-Lopez M</pubmed_authors><pubmed_authors>Fernandez-Campos P</pubmed_authors><pubmed_authors>Del Rio-Estrada PM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Longitudinal Analysis of Urinary Cytokines and Biomarkers in COVID-19 Patients with Subclinical Acute Kidney Injury.</name><description>In hospitalized COVID-19 patients, disease progression leading to acute kidney injury (AKI) may be driven by immune dysregulation. We explored the role of urinary cytokines and their relationship with kidney stress biomarkers in COVID-19 patients before and after the development of AKI. Of 51 patients, 54.9% developed AKI. The principal component analysis indicated that in subclinical AKI, epidermal growth factor (EGF) and interferon (IFN)-α were associated with a lower risk of AKI, while interleukin-12 (IL-12) and macrophage inflammatory protein (MIP)-1β were associated with a higher risk of AKI. After the manifestation of AKI, EGF and IFN-α remained associated with a lower risk of AKI, while IL-1 receptor (IL-1R), granulocyte-colony stimulating factor (G-CSF), interferon-gamma-inducible </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-20T03:33:32.637Z</modification><creation>2025-04-20T03:33:32.637Z</creation></dates><accession>S-EPMC9737068</accession><cross_references><pubmed>36499745</pubmed><doi>10.3390/ijms232315419</doi></cross_references></HashMap>